HPA-1 genotype in arterial thrombosis - Role of HPA-1b polymorphism in platelet function

Blood Coagulation and Fibrinolysis

Volumn 8, Issue 5, 1997, Pages 284-290

  Corral, J ^a   Gonzalez Conejero R ^a   Rivera, J ^a   Iniesta, J A ^a   Lozano, M L ^a   Vicente, V ^a,b  

^a HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b HOSPITAL UNIVERSITARIO MORALES MESEGUER   (Spain)

Author keywords

Cerebrovascular disease; Coronary artery disease; Genetic risk factors; HPA 1; Platelet glycoprotein polymorphism

Indexed keywords

FIBRINOGEN RECEPTOR; GLYCOPROTEIN IIIA; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTE FUNCTION;

EID: 0030796991     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199707000-00004     Document Type: Article

References (25)

1. Wu KK, Phillips M, Souza DD, Hellums JD. Platelet activation and arterial thrombosis. Lancet 1994; 334: 991-995.
2. Phillips DR, Charo IF, Scarborough RM. GPIIb-IIIa: the responsive integrin. Cell 1991; 65: 359-362.
3. Nurden AT. Polymorphism of human membrane glycoproteins: structure and clinical significance. Thromb Haemostasis 1995; 74: 345-351.
4. De Waal LP, van Dalen CM, Engelfriet CP, von dem Borne AEGKR. Alloimmunization against platelet-specific Zw(a) antigen resulting in neonatal alloimmune thrombocytopenia or post transfusion purpura, is associated with the super trypic DRw52 antigen including DR3 and DR6. Human Immunol 1986; 17: 45-48.
5. Mueller-Eckhardt C, Kuenzlen E. Alloimmune thrombocytopenia of the new-born. In: Engelfriet CP, van Loghem JJ, von dem Borne AEGK, eds. Immunohaematology. Amsterdam: Elsevier, 1984: 165.
6. Newman PJ, Derbers RS, Aster RH. The human platelet alloantigens PlA1 and PlA2 are associated with a leucine 33/proline 33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest 1989; 83: 1778-1781.
7. Zimrin AB, Gidwitz S, Lord S, et al. The genomic organization of platelet glycoprotein IIIa. J Biol Chem 1990; 265: 8590-8595.
8. Simsek S, Faber NM, Bleeker PM, et al. Determination of human platelet antigen frequencies in the Dutch population by immunophenotyping and DNA (allele-specific restriction enzyme) analysis. Blood 1993; 81: 835-840.
9. Kim HO, Jin Y, Kickler TS, Blakemore K, Kwon OH, Bray PF. Gene frequencies of the five major human platelet antigens in African, American, white, and Korean populations. Transfusion 1995; 35: 863-867.
10. Kunicki TJ, Newman PJ. The molecular immunology of human platelet proteins. Blood 1992; 80: 1386-1404.
11. Weiss EJ, Bray PF, Tayback M, et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 1996; 334: 1090-1094.
12. Special Report from the National Institute of Neurological Disorders and Stroke. Classification of Cerebrovascular Diseases III. Stroke 1990; 21: 637-676.
13. World Heath Organization. Ischemic heart disease registers: report of the Fifth Work Group, including a second revision of the operating protocol, Copenhagen, Denmark, 26-29 April 1971. Copenhagen, Denmark: World Health Organization, Regional Office for Europe, 1971.
14. Jin Y, Dietz HC, Nurden A, Bray PF. Single strand conformation polymorphism analysis is a rapid and effective method for the identification of mutations and polymorphisms in the gene for glycoprotein IIIa. Blood 1993; 82: 2281-2288.
15. Peyruchaud O, Nurden A, Bourre F. Non-radioactive SSCP for genotyping human platelet alloantigens. Br J Haematol 1995; 89: 633-636.
16. Walsh PN, Mills DCB, White JG. Metabolism and function of human platelet washed by albumin density gradient separation. Br J Haematol 1977; 36: 281-288.
17. Rivera J, Sánchez-Roig MJ, Rosillo MC, Moraleda JM, Vicente V. Stability of glycoproteins Ib/IX and IIb/IIIa during preparation and storage of platelet concentrates: detection by binding assays with epitope defined monoclonal antibodies and physiological ligands. Vox Sang 1994; 67: 166-171.
18. Fracker DJ, Speck JC. Protein and cell membrane iodinations with sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril. Biochem Biophys Res Commun 1978; 80: 849-857.
19. Munson PJ, Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand binding system. Anal Biochem 1980; 107: 220-239.
20. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-644.
21. Wenzel K, Felix S, Kleber FX, et al. E-selectin polymorphism and atherosclerosis: an association study. Hum Mol Gen 1994; 3: 1935-1937.
22. A2 (+) individuals. Blood 1996, 88: 26a (abstract).
23. Marian AJ, Brugada R, Kleiman N. Platelet glycoprotein IIIa PlA polymorphism and myocardial infarction. N Engl J Med 1996; 335: 1071-1072 (letter).
24. Carter AM, Ossei-Gerning N, Grant PJ. Platelet Glycoprotein IIIa PlA polymorphism and myocardial infarction. N Engl J Med 1996; 335: 1072-1073 (letter).
25. A1/A2 polymorphism of platelet glycoprotein IIIa and risk of myocardial infarction, stroke, and venous thrombosis. Lancet 1997; 349: 385-388.